Sartorius Stedim, FR0013154002

UBS keeps EUR 260.00 target for Sartorius Stedim; stock pre-market at EUR 220.40

Published on 10/16/2026 at 08:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sartorius Stedim stock was at EUR 220.40 pre-market at Lang & Schwarz on October 16, 2026. UBS retained its Buy rating and EUR 260.00 target ahead of expected quarterly results.

Analyst view and results date

  • UBS retained its Buy rating and EUR 260.00 target for Sartorius Stedim in a report dated October 15, 2026.
  • Sartorius Stedim stock was at EUR 220.40 at 8:15 a.m. CEST at Lang & Schwarz on October 16, 2026.
  • The company’s quarterly results are expected on October 22, 2026.
Sartorius Stedim Biotech Flatlay mit Laborpipetten, Filtermembranen, Aktien-Zertifikat und ISIN-Karte, ISIN FR0013154002, Illustration mit AI erstellt.

UBS retained its Buy rating and EUR 260.00 price target for Sartorius Stedim in a report dated October 15, 2026, according to Head Topics. The report said UBS was looking ahead to the company’s expected quarterly results on October 22, 2026.

Pre-market price

Sartorius Stedim stock was at EUR 220.40 at 8:15 a.m. CEST on October 16, 2026, in pre-market trading at Lang & Schwarz. The bid was EUR 219.80 and the ask was EUR 221.00. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Sartorius Stedim stock.

What matters today

The next company date identified in the report is October 22, 2026, when quarterly results are expected. A round-number reference level is EUR 220.00, which is EUR 0.40, or 0.18 percent, below the Lang & Schwarz indication. UBS’s reported target is EUR 260.00, based on its October 15, 2026 assessment.

Market context: Market report CAC 40.

More news and analysis on Sartorius Stedim stock

Disclaimer...
en | FR0013154002 | SARTORIUS STEDIM | boerse | 70336620 | bgmi